Related Experiment Video
Updated: Aug 11, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Carotid restenosis: operative and endovascular management
R W Hobson1, J E Goldstein, Z Jamil
1Division of Vascular Surgery, St. Michaels Medical Center, New Jersey, USA.
Insights
Carotid restenosis (CR) after carotid endarterectomy (CEA) can be treated with surgery or carotid angioplasty-stenting (CAS). Both methods show comparable complication rates, with CAS emerging as a potentially preferred option for managing CR.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Cardiovascular Disease Management
Background:
- Carotid restenosis (CR) following carotid endarterectomy (CEA) presents a higher perioperative complication risk compared to primary CEA.
- Surgical management of CR has historically been associated with increased risks.
- Carotid angioplasty-stenting (CAS) has emerged as a less invasive alternative for CR management.
Purpose of the Study:
- To compare the outcomes of carotid angioplasty-stenting (CAS) with operative management for carotid restenosis (CR) in patients previously treated with carotid endarterectomy (CEA).
- To evaluate the safety and efficacy of CAS as an alternative to surgery for CR.
- To assess the perioperative complication rates associated with different CR management strategies.
Main Methods:
- Retrospective analysis of patients undergoing management for CR after CEA.
- Comparison of outcomes between operative management (n=16) and CAS (n=16 patients, 17 procedures).
- Data collected on stroke, death, and other perioperative complications within 30 days.
Main Results:
- Overall CEA (n=1065) had a 1.4% stroke/death rate.
- Operative management of CR (n=16) resulted in no strokes or deaths, with one recurrent laryngeal nerve palsy (6.2%).
- CAS (n=17 procedures) demonstrated no strokes or deaths, with successful technical accomplishment in all cases and no identified recurrent restenosis.
Conclusions:
- Both operative techniques and CAS are viable options for managing CR caused by myointimal hyperplasia, with comparable periprocedural complication rates.
- CAS may become the preferred procedure for CR management, pending long-term follow-up data on recurrent restenosis.
- A randomized clinical trial is necessary to definitively establish the role of CAS versus operative management for CR.
Purpose:
Surgical management of carotid restenosis (CR) after carotid endarterectomy (CEA) has been associated with a higher perioperative complication rate than that of primary CEA. We recently used carotid angioplasty-stenting (CAS) as an alternative to operative management in patients who had undergone CEA within three years, and we retrospectively compared these results with those of operative management of CR and the overall results of CEA.
Methods:
CEA was performed on 1065 adult patients (58% symptomatic, 42% asymptomatic), 62% of whom were men (n = 660) and 38% of whom were women (n = 405), from 1989 to 1997. Before our initiation of a program of CAS, 16 operative procedures (1.9% of CEAs) were performed for CR in 14 adult patients (7 women and 7 men). During the last 20 months, CAS was used in the management of 17 CRs (16 patients; 9 women and 7 men).
Results:
The 30-day stroke morbidity-death rate for all CEAs (n = 1065) was 1.4%; 11 strokes (1. 0%) occurred (4 major strokes with disability and 7 strokes with minor or no disability), and 4 deaths (0.4%) occurred (2 deaths caused by myocardial infarction, 1 caused by intracranial hemorrhage, and 1 caused by stroke). Operative management of CR (n = 16) included patch angioplasty in 12 cases (autologous vein patches in 10 cases and synthetic patches in 2 cases), whereas interposition grafting was used in 4 cases (saphenous vein in 3 instances and synthetic [polytetrafluoroethylene] in one case). No strokes or deaths were observed. One recurrent laryngeal nerve palsy occurred (6.2%). Among the 16 patients undergoing 17 CAS procedures, the technical procedures were accomplished in all patients. No strokes or deaths occurred. No recurrent restenoses (50% or greater) have been identified within or adjacent to the CAS procedures.
Conclusion:
CR caused by myointimal hyperplasia can be managed by operative techniques or CAS with comparable periprocedural complications. Although long-term follow-up will be required to determine the incidence of recurrent restenosis, CAS may become the preferred procedure in these cases. A randomized clinical trial ultimately will be necessary to determine the role of CAS, as compared with that of operative management.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management

